Free shipping on all orders over $ 500

AZD1080

Cat. No. M2417

All AbMole products are for research use only, cannot be used for human consumption.

AZD1080 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 55 In stock
5mg USD 85 In stock
10mg USD 140 In stock
25mg USD 240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively, shows >14-fold selectivity against CDK2, CDK5, CDK1 and Erk2. AZD1080,with IC50 of 324 nM, inhibits tau phosphorylation in cells expressing human tau. AZD1080 inhibits tau phosphorylation in rat brain after oral dministration, with brain/plasma exposure ratio of 0.5 – 0.8 at peak concentrations. AZD1080 reverses cognitive deficits and rescues dysfunctional synapses in mice. Acute oral treatment with AZD1080 inhibits peripheral GSK3 activity, produces a dose-dependent reduction of the phosphorylated to total glycogen synthase (GS) ratio, with a mean maximal inhibitory effect of 49% at the highest dose (10 μmol/kg) at 2 h after dosing.

Customer Product Validations & Biological Datas
Source Oncotarget (2016). Figure 10. AZD1080
Method cell proliferation assay
Cell Lines EC cell
Concentrations 1.0, 2.0, 4.0 μM
Incubation Time 0 h, 24 h, 48 h, and 72 h
Results The MTT assay showed a significant reduction of cell viability started from 0.5 μM when exposed to AZD1080 compared with the DMSO group, and thus the www.impactjournals.com/oncotarget 27546 Oncotarget concentration of 1.0, 2.0, 4.0μM was used for further study
Chemical Information
Molecular Weight 334.37
Formula C19H18N4O2
CAS Number 612487-72-6
Solubility (25°C) DMSO 18 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Georgievska B,et al. J Neurochem. AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.

Related GSK-3 Products
CHIR-99021

CHIR-99021 (CT99021) is an aminopyrimidine derivative that inhibits GSK3α and GSK3β with IC50 values of 10 and 6.7 nM, respectively.

CHIR-99021 HCl

CHIR-99021 HCl (Laduviglusib; CT99021) is a hydrochloride of CHIR-99021, with IC50 of 10 nM and 6.7 nM for GSK-3α and GSK-3β, respectively.

SB 216763

SB 216763 is a potent and selective, cell permeable glycogen synthase kinase-3 (GSK-3) inhibitor with an IC50 value of 34 nM for GSK-3α.

AZD2858

AZD2858 is a potent, orally bioactive inhibitor of GSK-3 with an IC50 of 68 nM.

Indirubin

Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of ~75 nM and 0.19 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: AZD1080 supplier, GSK-3, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.